Intermittent Preventive Treatment of Malaria in Pregnancy with Mefloquine in HIV-Negative Women: A Multicentre Randomized Controlled Trial
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) is recommended by WHO to prevent malaria in African pregnant women. The spread of SP parasite resistance has raised concerns regarding long-term use for IPT. Mefloquine (MQ) is the most promising of available alternatives to SP based on safety profile, long half-life, and high efficacy in Africa. We evaluated the safety and efficacy of MQ for IPTp compared to those of SP in HIV-negative women. METHODS AND FINDINGS: A total of 4,749 pregnant women were enrolled in an open-label randomized clinical trial conducted in Benin, Gabon, Mozambique, and Tanzania comparing two-dose MQ or SP for IPTp and MQ tolerability of two different regimens. The study arms were: (1) SP, (2) single dose MQ (15 mg/kg), and (3) split-dose MQ in the context of long lasting insecticide treated nets. There was no difference on low birth weight prevalence (primary study outcome) between groups (360/2,778 [13.0%]) for MQ group and 177/1,398 (12.7%) for SP group; risk ratio [RR], 1.02 (95% CI 0.86-1.22; p=0.80 in the ITT analysis). Women receiving MQ had reduced risks of parasitemia (63/1,372 [4.6%] in the SP group and 88/2,737 [3.2%] in the MQ group; RR, 0.70 [95% CI 0.51-0.96]; p=0.03) and anemia at delivery (609/1,380 [44.1%] in the SP group and 1,110/2743 [40.5%] in the MQ group; RR, 0.92 [95% CI 0.85-0.99]; p=0.03), and reduced incidence of clinical malaria (96/551.8 malaria episodes person/year [PYAR] in the SP group and 130/1,103.2 episodes PYAR in the MQ group; RR, 0.67 [95% CI 0.52-0.88]; p=0.004) and all-cause outpatient attendances during pregnancy (850/557.8 outpatients visits PYAR in the SP group and 1,480/1,110.1 visits PYAR in the MQ group; RR, 0.86 [0.78-0.95]; p=0.003). There were no differences in the prevalence of placental infection and adverse pregnancy outcomes between groups. Tolerability was poorer in the two MQ groups compared to SP. The most frequently reported related adverse events were dizziness (ranging from 33.9% to 35.5% after dose 1; and 16.0% to 20.8% after dose 2) and vomiting (30.2% to 31.7%, after dose 1 and 15.3% to 17.4% after dose 2) with similar proportions in the full and split MQ arms. The open-label design is a limitation of the study that affects mainly the safety assessment. CONCLUSIONS: Women taking MQ IPTp (15 mg/kg) in the context of long lasting insecticide treated nets had similar prevalence rates of low birth weight as those taking SP IPTp. MQ recipients had less clinical malaria than SP recipients, and the pregnancy outcomes and safety profile were similar. MQ had poorer tolerability even when splitting the dose over two days. These results do not support a change in the current IPTp policy. TRIAL REGISTRATION: ClinicalTrials.gov NCT 00811421; Pan African Clinical Trials Registry PACTR 2010020001429343 Please see later in the article for the Editors' Summary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology and burden of malaria in pregnancy
Desai, M., ter Kuile, F. O., Nosten, F., McGready, R., Asamoa, K., Brabin, B., & Newman, R. D. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70021-x · Cited by 1,432
The Impact of Placental Malaria on Gestational Age and Birth Weight
Menendez, C., Ordi, J., Ismail, M. R., Ventura, P. J., Aponte, J. J., Kahigwa, E., Font, F., & Alonso, P. L. (2000) · The Journal of Infectious Diseases · doi:10.1086/315449 · Cited by 467
Self-citationO. ter Kuile, F., van Eijk, A. M., & Filler, S. J. (2007) · JAMA · doi:10.1001/jama.297.23.2603 · Cited by 355
Placental pathology in malaria: A histological, immunohistochemical, and quantitative study
Ismail, M. R., Ordi, J., Menendez, C., Ventura, P. J., Aponte, J. J., Kahigwa, E., Hirt, R., Cardesa, A., & Alonso, P. L. (2000) · Human Pathology · doi:10.1016/s0046-8177(00)80203-8 · Cited by 328
Self-citationMassive chronic intervillositis of the placenta associated with malaria infection
Ordi, J., Ismail, M. R., Ventura, P. J., Kahigwa, E., Hirt, R., Cardesa, A., Alonso, P. L., & Menendez, C. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199808000-00011 · Cited by 265
Reducing the burden of malaria in pregnancy by preventive strategies
Menéndez, C., D'Alessandro, U., & ter Kuile, F. O. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70024-5 · Cited by 188 · cited 1×
“Thus, pregnant women are a vulnerable group for malaria who require particular attention [5], which is especially relevant in the African region where nearly 30 million pregnancies occur every year in areas where there is stable transmission of Plasmodium falciparum, the most deleterious of the human malaria parasites…”
BackgroundSelf-citationMenéndez, C., Bardají, A., Sigauque, B., Romagosa, C., Sanz, S., Serra-Casas, E., Macete, E., Berenguera, A., David, C., Dobaño, C., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001934 · Cited by 166 · cited 3×
“Some previous chemoprophylaxis and IPT trials in pregnant women have documented a lack of effect on birth weight of these malaria preventive strategies [9,23,39].”
BackgroundMethodSelf-citationRogerson, S. J., Mkundika, P., & Kanjala, M. K. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.4.1370-1374.2003 · Cited by 113
Briand, V., Bottero, J., Noël, H., Masse, V., Cordel, H., Guerra, J., Kossou, H., Fayomi, B., Ayemonna, P., Fievet, N., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/605474 · Cited by 98
Self-citationClinical malaria in African pregnant women
Bardají, A., Sigauque, B., Bruni, L., Romagosa, C., Sanz, S., Mabunda, S., Mandomando, I., Aponte, J., Sevene, E., Alonso, P. L., et al. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-27 · Cited by 68 · cited 1×
“5uC) in the last 24 hours, and/or pallor and/or arthromyalgias and/or headache and/or history of convulsions [36].”
Self-citation
Cited by
Fried, M., & Duffy, P. E. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025551 · Cited by 202
Prevention of malaria in pregnancy
Desai, M., Hill, J., Fernandes, S., Walker, P., Pell, C., Gutman, J., Kayentao, K., Gonzalez, R., Webster, J., Greenwood, B., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30064-1 · Cited by 153
Self-citationMombo-Ngoma, G., Mackanga, J. R., González, R., Ouedraogo, S., Kakolwa, M. A., Manego, R. Z., Basra, A., Rupérez, M., Cot, M., Kabanywany, A. M., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011783 · Cited by 104
Self-citationMalaria, malnutrition, and birthweight: A meta-analysis using individual participant data
Cates, J. E., Unger, H. W., Briand, V., Fievet, N., Valea, I., Tinto, H., D’Alessandro, U., Landis, S. H., Adu-Afarwuah, S., Dewey, K. G., et al. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002373 · Cited by 74
“We excluded 5 studies: 2 studies did not assess malaria at antenatal enrollment [42,43], 1 study had data that were not yet available for inclusion [44], 1 recruited women comparatively late in pregnancy [10], and 1 had not directly measured the number of sulfadoxinepyrimethamine (SP) doses given for IPTp [45].”
ResultSelf-citationChico, R. M., Chaponda, E. B., Ariti, C., & Chandramohan, D. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix026 · Cited by 68
Metadata
- Authors
- González, R., Mombo-Ngoma, G., Ouédraogo, S., Kakolwa, M. A., Abdulla, S., Accrombessi, M., Aponte, J. J., Akerey-Diop, D., Basra, A., Briand, V., Capan, M., Cot, M., Kabanywanyi, A. M., Kleine, C., Kremsner, P. G., Macete, E., Mackanga, J.-R., Massougbodgi, A., Mayor, A., Nhacolo, A., Pahlavan, G., Ramharter, M., Rupérez, M., Sevene, E., Vala, A., Zoleko-Manego, R., & Menéndez, C.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-09-23
- Volume
- 11
- Issue
- 9
- Pages
- e1001733
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2129955913
- Cited by
- 136
- References
- 12
- FWCI
- 17.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intermittent Preventive Treatment of Malaria in Pregnancy with Mefloquine in HIV-Negative Women: A Multicentre Randomized Controlled Trial. https://app.cochat.ai/papers/10.1371/journal.pmed.1001733
- The paper
- González, R., Mombo-Ngoma, G., Ouédraogo, S., Kakolwa, M. A., Abdulla, S., Accrombessi, M., Aponte, J. J., Akerey-Diop, D., Basra, A., Briand, V., Capan, M., Cot, M., Kabanywanyi, A. M., Kleine, C., Kremsner, P. G., Macete, E., Mackanga, J.-R., Massougbodgi, A., Mayor, A., . . . Menéndez, C. (2014). Intermittent Preventive Treatment of Malaria in Pregnancy with Mefloquine in HIV-Negative Women: A Multicentre Randomized Controlled Trial. PLoS Medicine. https://doi.org/10.1371/journal.pmed.1001733
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.